114 related articles for article (PubMed ID: 32828317)
1. Phosphofructokinase-M inhibits cell growth via modulating the FOXO3 pathway in renal cell carcinoma cells.
Chen Y; Yu Q; Duan X; Wu W; Zeng G
Biochem Biophys Res Commun; 2020 Sep; 530(1):67-74. PubMed ID: 32828317
[TBL] [Abstract][Full Text] [Related]
2. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
[TBL] [Abstract][Full Text] [Related]
5. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
6. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
7. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
8. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
9. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
10. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
11. HSPA12A unstabilizes CD147 to inhibit lactate export and migration in human renal cell carcinoma.
Min X; Zhang X; Li Y; Cao X; Cheng H; Li Y; Li C; Kong Q; Mao Q; Peng P; Ni Y; Li J; Duan Y; Liu L; Ding Z
Theranostics; 2020; 10(19):8573-8590. PubMed ID: 32754264
[No Abstract] [Full Text] [Related]
12. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
[TBL] [Abstract][Full Text] [Related]
13. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X
J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
Tong Z; Meng X; Wang J; Wang L
Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
[TBL] [Abstract][Full Text] [Related]
18. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
[TBL] [Abstract][Full Text] [Related]
19. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
Chen F; Bai J; Li W; Mei P; Liu H; Li L; Pan Z; Wu Y; Zheng J
PLoS One; 2013; 8(2):e56241. PubMed ID: 23457532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]